Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Menjugate recall

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a recall for Menjugate Kit vaccine, a meningococcal group C conjugate vaccine.

The recall applies to two batches (235012A and 236011) and is a precautionary measure following the failure of one of the vaccines ingredients to pass a sterility test.

Information provided by the MHRA indicates that both of the above batches of vaccine have passed all tests, including the sterility test however these batches are being recalled as a precautionary measure to ensure that there are no grounds for anyone to be concerned.

Parents who are concerned about this recall are advised to contact their doctor. Different vaccines and different batches of Menjugate are not affected by this recall.

Action: Clinicians should be aware of this recall and ensure that appropriate action is undertaken. Worried parents can be reassured if it is found that a different batch of Menjugate has been used.

Share 'Menjugate recall' on Email Share 'Menjugate recall' on Delicious Share 'Menjugate recall' on Digg Share 'Menjugate recall' on Facebook Share 'Menjugate recall' on Google+ Share 'Menjugate recall' on reddit Share 'Menjugate recall' on StumbleUpon Share 'Menjugate recall' on Twitter

atomic-wealth

No Comments to “Menjugate recall”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer